Haemonetics Corp/ US4050241003 /
11/10/2024 19:11:23 | Chg. +1.13 | Volume | Bid11/10/2024 | Ask11/10/2024 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
75.58USD | +1.52% | 192,259 Turnover: 10.53 mill. |
75.53Bid Size: 700 | 75.63Ask Size: 1,000 | 3.87 bill.USD | - | 32.58 |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 321.9480 | 337.6340 | 323.8620 | 332.1560 | 343.9790 | ||||||
Intangible Assets | 244.5880 | 204.4580 | 177.5400 | 156.5890 | 127.6930 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 915.1400 | 831.0420 | 728.6800 | 716.1620 | 698.6460 | ||||||
Inventories | 211.0770 | 187.0280 | 176.9290 | 160.7990 | 194.3370 | ||||||
Accounts Receivable | 145.8270 | 157.0930 | 152.6830 | 151.2260 | 185.0270 | ||||||
Cash and Cash Equivalents | 160.6620 | 115.1230 | 139.5640 | 180.1690 | 169.3510 | ||||||
Current Assets | 570.2770 | 488.0860 | 510.0290 | 521.1770 | 576.1210 | ||||||
Total Assets | 1,485.4170 | 1,319.1280 | 1,238.7090 | 1,237.3390 | 1,274.7670 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 48.4250 | 39.6740 | 42.9730 | 55.2650 | 63.3610 | ||||||
Long-term debt | 406.3690 | 364.5290 | 253.6250 | 59.4230 | 322.4540 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | 32.1000 | 21.4000 | 12.1000 | 6.5000 | 19.9000 | ||||||
Liabilities | 659.2950 | 597.5630 | 499.0990 | 484.9100 | 606.8990 | ||||||
Share Capital | .5170 | .5090 | .5230 | .5230 | .5100 | ||||||
Total Equity | 826.1220 | 721.5650 | 739.6100 | 752.4290 | 667.8680 | ||||||
Minority Interests | - | - | - | - | - | ||||||
Total liabilities equity | 1,485.4170 | 1,319.1280 | 1,238.7090 | 1,237.3390 | 1,274.7670 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 910.3730 | 908.8320 | 886.1160 | 903.9230 | 967.5790 | ||||||
Depreciation (total) | 86.0530 | 89.9110 | 89.7330 | 89.2470 | 109.4180 | ||||||
Operating Result | 40.5400 | -43.9420 | -19.3810 | 56.1570 | 83.5450 | ||||||
Interest Income | -9.3750 | -9.4740 | -8.0950 | -4.5250 | -9.9120 | ||||||
Income Before Taxes | 31.1650 | -53.4160 | -27.4760 | 59.6320 | 73.6330 | ||||||
Income Taxes | 14.2680 | 2.1630 | -1.2080 | 14.0600 | 18.6140 | ||||||
Minority Interests Profit | - | - | - | - | - | ||||||
Net Income | 16.8970 | -55.5790 | -26.2680 | 45.5720 | 55.0190 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 127.1780 | 121.8650 | 159.7380 | 220.3500 | 159.2810 | ||||||
Cash Flow from Investing Activities | -121.7680 | -104.7680 | -73.3130 | -63.0410 | -116.1480 | ||||||
Cash Flow from Financing | -33.1600 | -62.6240 | -60.4130 | -120.6430 | -50.6280 | ||||||
Decrease / Increase in Cash | -31.8070 | -45.5390 | 24.4410 | 40.6050 | -10.8180 | ||||||
Employees | 3,383 | 3,225 | 3,107 | 3,136 | 3,216 |